Apolipoprotein B (apoB) testing may offer a more precise assessment of heart attack and stroke risk than standard cholesterol panels, according to research from Northwestern Medicine published in JAMA. While millions of Americans currently track LDL and non-HDL cholesterol, experts suggest apoB provides a clearer picture of the particles that contribute to arterial buildup.
Why apoB testing offers a clearer risk profile
Standard lipid panels often track LDL, frequently referred to as “bad” cholesterol. However, Northwestern Medicine researchers found that tracking apoB—a protein found on particles that deposit cholesterol into artery walls—can be more effective at identifying patients who require medical intervention. The American Heart Association notes that in some cases, a patient’s LDL levels may appear within a healthy range, while their apoB levels remain elevated. When this occurs, a standard test may fail to reflect the true extent of a person’s cardiovascular risk.
ApoB is a protein found on the particles that can deposit cholesterol in artery walls.
How recent guidelines are changing heart health screening
The medical community is shifting toward more comprehensive screening methods to combat heart disease, which remains the leading cause of death in the U.S. according to the American Heart Association. Earlier this year, a coalition including the American Heart Association and the American College of Cardiology issued updated guidelines for cholesterol management.
These updated standards now recommend that patients have their Lipoprotein (a), or Lp(a), measured at least once during adulthood. Unlike standard cholesterol, Lp(a) is a genetic marker. Medical associations emphasize that higher levels of Lp(a) correlate with an increased long-term risk of heart attack and stroke. Like other lipid tests, this is performed via a routine blood sample.
Comparing traditional and advanced lipid testing
Understanding the difference between these tests is essential for patient advocacy. While traditional LDL testing has been used, emerging research suggests it may not tell the whole story.
| Test Type | Primary Focus |
|---|---|
| LDL/Non-HDL | Standard cholesterol tracking. |
| ApoB | Protein on particles that deposit cholesterol in artery walls. |
| Lp(a) | Genetic marker of heart disease risk. |
Frequently Asked Questions
While guidelines are evolving, many standard physicals still rely on traditional lipid panels. You should ask your healthcare provider if an apoB or Lp(a) test is appropriate based on your personal and family medical history.
High cholesterol, alongside high blood pressure, diabetes, and smoking, increases cardiovascular risk. Consult your doctor to discuss lifestyle changes or medication as indicated by current American Heart Association guidelines.
Have you discussed advanced cholesterol testing with your physician? Share your experiences in the comments below or subscribe to our health newsletter for the latest medical updates.
